Registry Study of Proton Radiotherapy in Lymphoma
About this study
The aim is to record and document a mediastinal PT and the corresponding follow-up data (effectiveness and side effects). General recommendations for planning and feasibility are made within the framework of this study.
- Condition
- Mediastinal Lymphoma
- Tested
- Assesment of Effectiveness and side effects
- Sponsor
- University Hospital Heidelberg
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 7
- Minimum age: 18 years
- Study condition: Mediastinal Lymphoma
- Histologically confirmed lymphoma according to WHO
- Patient consent
- Patient age ≥18 years.
- Presence of the need for mediastinal radiotherapy and the presumed benefit of mediastinal radiotherapy using protons in comparison to photon radiation (e.g. improved heart, lungs, and breast protection compared to photon radiation).
- Ability of the patient to give consent
Exclusion 3
- Age \<18 years
- Non-consent of the patient to the disclosure of his data
- Cancellation of the patient's participation in the study
Where
1 site, 1 recruiting
University Hospital Heidelberg
Heidelberg, Germany
Contact
-
Laila König, MD
+49 6221 laila.könig@med.uni-heidelberg.de
-
Adriane Hommertgen, Phd
Potential match only. Final eligibility is determined by the study team.